Stem Cells Market

Stem Cells Market (Product Type: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, and Others; Source; Application and End-user) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Stem Cells Market Outlook 2028

  • The global market was valued at over US$ 11.73 Bn in 2020
  • It is estimated to expand at a CAGR of 10.4% from 2021 to 2028
  • The global market for stem cells is expected to reach the value of US$ 25.68 Bn by the end of 2028

Analysts’ Viewpoint on Market Scenario

Stem cells are used in treating various illnesses in the body. Technological advancements in healthcare and pharmaceutical industries are creating potential revenue opportunities for market players operating in the stem cells market. Increasing investments in R&D activities to explore innovative ways to use stem cells for different healthcare applications are driving the global market. The growing incidences of diseases such as cancer, diabetes, and heart diseases boost the demand for stem cells. Market players are exploring new approaches to culturing or utilizing stem cells in various applications. Rapid expansion of pharmaceutical companies and clinical research institutes in developed regions is fueling the growth of the market. High cost is a major factor affecting the growth of the global market for stem cells. Companies in the stem cells industry should experiment with new techniques to improvise the testing processes.

Increasing Demand for Stem Cells in Regenerative Medicines Accelerates Market Growth

The global stem cell market is majorly driven by rising applications of stem cells in regenerative medicines. An increase in the number of chronic diseases such as cardiac diseases, diabetes, cancer, etc. across the globe is responsible for market growth. Regenerative medicines are used in the treatment of various diseases and are made using stem cells in order to repair injured tissue. The rising clinical trials for regenerative medicines, along with increasing development in stem cell-based therapies is the factor creating value-grab opportunities for the market players. Companies operating in the global stem cells market are conducting basic research and preclinical trials for testing the regenerative capacity of stem cells in the treatment of various neurological conditions. With consistent efforts of scientists and R&D activities in stem cell biologics, market players are gaining lucrative growth opportunities in the global market.

To know the scope of our report Get a Sample of the Stem Cells Market

Rising Healthcare Expenditure and Increasing Investment in R&D Activities

There have been a lot of research & development activities in the field of stem cell biologics. The high demand for stem cells in therapeutic treatments for neurological disorders, cancer, heart diseases, diabetes, etc. is driving the global market, creating lucrative revenue opportunities for manufacturers in the stem cells market. Governments are taking steps to support pharmaceutical companies, and investing in research and development activities. Manufacturers are bolstering their R&D capabilities to experiment with new technologies and applications. Manufacturers operating in the global stem cell market are using technological innovations to stay ahead of the competition and generate more revenue opportunities. Increasing healthcare expenditure, research & development activities, and trending advances in biologics strengthen the scope and expansion of the stem cells business.

Get a glimpse of the in-depth analysis through our Report Brochure

An increase in Funding for Stem Cell Research Generates Potential Opportunities

Increasing applications of stem cells for many health conditions and chronic diseases that affect millions of people globally. Consistent research in the field of stem cells is one of the key factors driving the growth of the market. Funding provided by governments and other private organizations to carry out extensive research on stem cells is encouraging market stakeholders to pave their way in the global market by providing treatment for various chronic illnesses. The stem cell market is expected to witness an abundance of growth opportunities in the upcoming years. The increasing number of chronic illnesses is anticipated to revive the growth of the stem cell market.

Expanding operations in the future? To get the perfect launch to ask for a custom report

North America Market Players Offering Profitable Revenue Opportunities

North America is expected to account for a major share of the global stem cells market during the forecast period. The North American stem cell market is majorly driven by the increasing prevalence of lifestyle diseases such as diabetes, cancer, heart diseases, etc. in the region. In addition, technological advancements in healthcare, increasing investment in research & development activities, and a growing number of diagnostic facilities are some of the key factors fueling market growth in North America. Manufacturers operating in the global market are shifting toward electronic medical devices to increase the performance of services. Countries in the Asia Pacific such as China and India are responsible for the fastest growth of stem cell business in the region. Moreover, rapid urbanization and increasing spending on healthcare are factors contributing to the market growth in the Asia Pacific.

Stem Cells Industry: Overview

  • According to Transparency Market Research’s latest report on the global stem cells market for the historical period 2017–2019 and forecast period 2021–2028, Increasing health care expenditure in developing countries is projected to drive the global market for stem cells during the forecast period

Increase in Funding for Stem Cell Research: Key Driver

  • Stem cells hold the promise for treatments and cures of more than 70 major diseases and conditions that affect millions of people globally. Several private and government sectors support funding for stem cell research.
    • According to Change.org, Inc., in the U.S., 64% of the people support federal funding of research on chronic diseases using stem cells taken from human embryos
  • Internationally, stem cell research is supported by significant government investments, with Asia being one of the most favorable regions. Stem cell research funding by the National Institutes of Health (NIH) has been increasing in the past few years.

Rise in Stem Cell Banking Services to Boost Market Growth

  • Umbilical cord blood provides a pool of hematopoietic and mesenchymal stem cells, which can be stored after childbirth for later use. The stored blood finds applications in the treatment of hematological disorders such as leukemia, lymphoma, and sickle cell anemia.
  • The cost of storage is high, and according to the American Academy of Pediatrics, the odds that a person will require cord blood stem cells are 1:1,000
  • Nevertheless, parents opt for the storage and over 20,000 people in the U.S. have undergone surgeries, which have utilized stored umbilical cord blood

High Treatment Cost to Hamper Market

  • Stem cell treatment is expensive; a major proportion of the global population cannot afford it
    • For instance, a full treatment with Prochymal, a stem cell-based drug approved in Canada to alleviate pediatric rejection of bone marrow transplants, is estimated to cost around US$ 200,000
    • This substantiates the fact that only a small proportion of the population of world is capable of spending on stem cell therapies

Stem Cells Market: Competition Landscape

  • This report profiles major players in the global stem cells market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global market for stem cells is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global stem cells business are
    • STEMCELL Technologies, Inc.
    • Astellas Pharma, Inc.
    • Cellular Engineering Technologies, Inc.
    • BioTime, Inc.
    • Takara Bio, Inc.
    • U.S. Stem Cell, Inc.
    • BrainStorm Cell Therapeutics, Inc.
    • Cytori Therapeutics, Inc.
    • Osiris Therapeutics, Inc.
    • Caladrius Biosciences, Inc., among others

Stem Cells Market: Key Developments

  • Key players in the global stem cells industry are engaged in regulatory approvals, technologically advanced products, the launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global stem cell market. A few expansion strategies adopted by players operating in the global stem cells market are:
    • In February 2018, Astellas Pharma, Inc. acquired Universal Cells, Inc. in order to utilize technology to produce pluripotent stem cells
    • In March 2021, OrganaBio introduced HematoPAC ASC-cb CD34 hematopoietic stem cell product in order to support the HSC-based allogeneic cell therapies
  • The report on the global market for stem cells discusses individual strategies, followed by company profiles of manufacturers of stem cell products. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global market.

Stem Cells Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 11.73 Bn

Market Forecast Value in 2028

US$ 25.68 Bn

Growth Rate (CAGR)

10.4%

Forecast Period

2021–2028

Quantitative Units

US$ Bn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market Share Analysis by Company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • By Type
    • Adult Stem Cell
    • Human Embryonic Stem Cell
    • Induced Pluripotent Stem Cell
    • Others
  • By Source
    • Autologous
    • Allogenic
  • By Application
    • Regenerative Medicines
      • Neurology
      • Oncology
      • Cardiology
      • Others
    • Drug Discovery & Development
  • By End-user
    • Therapeutics Companies
    • Cell & Tissue Banks
    • Tools & Reagents Companies
    • Service Companies

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • STEMCELL Technologies, Inc.
  • Astellas Pharma, Inc.
  • Cellular Engineering Technologies, Inc.
  • BioTime, Inc.
  • Takara Bio, Inc.
  • U.S. Stem Cell, Inc.
  • BrainStorm Cell Therapeutics, Inc.
  • Cytori Therapeutics, Inc.
  • Osiris Therapeutics, Inc.
  • Caladrius Biosciences, Inc.
  • Others

Customization Scope

Available upon request

Pricing

Available upon request

Stem Cells Market – Segmentation

Product Type
  • Adult Stem Cell
  • Human Embryonic Stem Cell
  • Induced Pluripotent Stem Cell
  • Others
Source
  • Autologous
  • Allogenic
Application
  • Regenerative Medicines
    • Neurology
    • Oncology
    • Cardiology
    • Others
  • Drug Discovery & Development
End-user
  • Therapeutics Companies
  • Cell & Tissue Banks
  • Tools & Reagents Companies
  • Service Companies
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of stem cells market?

The global market for stem cells was worth US$ 11.73 Bn and is projected to reach a value of US$ 25.68 Bn by the end of 2028

What is the anticipated CAGR of the stem cell market in the forecast period?

The global market is anticipated to grow at a CAGR of 10.4% during the forecast period

Which region is expected to project the highest market share in the global market forstem cells?

North America accounted for a major share of the global market

What are the key driving factors for the growth of the stem cells business?

Stem cells market is majorly driven by rising applications of stem cells in regenerative medicines, Increase in the number of chronic diseases such as cardiac diseases, diabetes, cancer, etc. across the globe is responsible for market growth

Who are the key players in the global stem cells industry?

Key players in the global market for stem cells include STEMCELL Technologies, Inc., Astellas Pharma, Inc., Cellular Engineering Technologies, Inc., BioTime, Inc., Takara Bio, Inc., U.S. Stem Cell, Inc., BrainStorm Cell Therapeutics, Inc., Cytori Therapeutics, Inc., Osiris Therapeutics, Inc., and Caladrius Biosciences, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Stem Cells Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Type Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Stem Cells Market Analysis and Forecast, 2017–2028

            4.4.1. Market Revenue Projections (US$ Mn)

            4.4.2. Market Volume/Unit Shipments Projections

    5. Key Insights

        5.1. Disease Prevalence & Incidence Rate globally with key countries

        5.2. Key Industry Developments

        5.3. Pipeline Analysis

        5.4. COVID-19 Impact Analysis

    6. Global Stem Cells Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product Type, 2017–2028

            6.3.1. Adult Stem Cell

            6.3.2. Human Embryonic Stem Cell

            6.3.3. Induced Pluripotent Stem Cell

            6.3.4. Others

        6.4. Market Attractiveness Analysis, by Product Type

    7. Global Stem Cells Market Analysis and Forecast, by Source

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Source, 2017–2028

            7.3.1. Autologous

            7.3.2. Allogenic

        7.4. Market Attractiveness Analysis, by Source

    8. Global Stem Cells Market Analysis and Forecast, by Application

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Application, 2017–2028

            8.3.1. Regenerative Medicines

                8.3.1.1. Neurology

                8.3.1.2. Oncology

                8.3.1.3. Cardiology

                8.3.1.4. Others

            8.3.2. Drug Discovery & Development

        8.4. Market Attractiveness Analysis, by Application

    9. Global Stem Cells Market Analysis and Forecast, by End-user

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast, by End-user, 2017–2028

            9.3.1. Therapeutics Companies

            9.3.2. Cell & Tissue Banks

            9.3.3. Tools & Reagents Companies

            9.3.4. Service Companies

        9.4. Market Attractiveness Analysis, by End-user

    10. Global Stem Cells Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness Analysis, by Country/Region

    11. North America Stem Cells Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product Type, 2017–2028

            11.2.1. Adult Stem Cell

            11.2.2. Human Embryonic Stem Cell

            11.2.3. Induced Pluripotent Stem Cell

            11.2.4. Others

        11.3. Market Value Forecast, by Source, 2017–2028

            11.3.1. Autologous

            11.3.2. Allogenic

        11.4. Market Value Forecast, by Application, 2017–2028

            11.4.1. Regenerative Medicines

                11.4.1.1. Neurology

                11.4.1.2. Oncology

                11.4.1.3. Cardiology

                11.4.1.4. Others

            11.4.2. Drug Discovery & Development

        11.5. Market Value Forecast, by End-user, 2017–2028

            11.5.1. Therapeutics Companies

            11.5.2. Cell & Tissue Banks

            11.5.3. Tools & Reagents Companies

            11.5.4. Service Companies

        11.6. Market Value Forecast, by Country, 2017–2028

            11.6.1. U.S.

            11.6.2. Canada

        11.7. Market Attractiveness Analysis

            11.7.1. By Product Type

            11.7.2. By Source

            11.7.3. By Application

            11.7.4. By End-user

            11.7.5. By Country

    12. Europe Stem Cells Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product Type, 2017–2028

            12.2.1. Adult Stem Cell

            12.2.2. Human Embryonic Stem Cell

            12.2.3. Induced Pluripotent Stem Cell

            12.2.4. Others

        12.3. Market Value Forecast, by Source, 2017–2028

            12.3.1. Autologous

            12.3.2. Allogenic

        12.4. Market Value Forecast, by Application, 2017–2028

            12.4.1. Regenerative Medicines

                12.4.1.1. Neurology

                12.4.1.2. Oncology

                12.4.1.3. Cardiology

                12.4.1.4. Others

            12.4.2. Drug Discovery & Development

        12.5. Market Value Forecast, by End-user, 2017–2028

            12.5.1. Therapeutics Companies

            12.5.2. Cell & Tissue Banks

            12.5.3. Tools & Reagents Companies

            12.5.4. Service Companies

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2028

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Italy

            12.6.5. Spain

            12.6.6. Rest of Europe

        12.7. Market Attractiveness Analysis

            12.7.1. By Product Type

            12.7.2. By Source

            12.7.3. By Application

            12.7.4. By End-user

            12.7.5. By Country/Sub-region

    13. Asia Pacific Stem Cells Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product Type, 2017–2028

            13.2.1. Adult Stem Cell

            13.2.2. Human Embryonic Stem Cell

            13.2.3. Induced Pluripotent Stem Cell

            13.2.4. Others

        13.3. Market Value Forecast, by Source, 2017–2028

            13.3.1. Autologous

            13.3.2. Allogenic

        13.4. Market Value Forecast, by Application, 2017–2028

            13.4.1. Regenerative Medicines

                13.4.1.1. Neurology

                13.4.1.2. Oncology

                13.4.1.3. Cardiology

                13.4.1.4. Others

            13.4.2. Drug Discovery & Development

        13.5. Market Value Forecast, by End-user, 2017–2028

            13.5.1. Therapeutics Companies

            13.5.2. Cell & Tissue Banks

            13.5.3. Tools & Reagents Companies

            13.5.4. Service Companies

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2028

            13.6.1. Japan

            13.6.2. China

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of APAC

        13.7. Market Attractiveness Analysis

            13.7.1. By Product Type

            13.7.2. By Source

            13.7.3. By Application

            13.7.4. By End-user

            13.7.5. By Country/Sub-region

    14. Latin America Stem Cells Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product Type, 2017–2028

            14.2.1. Adult Stem Cell

            14.2.2. Human Embryonic Stem Cell

            14.2.3. Induced Pluripotent Stem Cell

            14.2.4. Others

        14.3. Market Value Forecast, by Source, 2017–2028

            14.3.1. Autologous

            14.3.2. Allogenic

        14.4. Market Value Forecast, by Application, 2017–2028

            14.4.1. Regenerative Medicines

                14.4.1.1. Neurology

                14.4.1.2. Oncology

                14.4.1.3. Cardiology

                14.4.1.4. Others

            14.4.2. Drug Discovery & Development

        14.5. Market Value Forecast, by End-user, 2017–2028

            14.5.1. Therapeutics Companies

            14.5.2. Cell & Tissue Banks

            14.5.3. Tools & Reagents Companies

            14.5.4. Service Companies

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2028

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of LATAM

        14.7. Market Attractiveness Analysis

            14.7.1. By Product Type

            14.7.2. By Source

            14.7.3. By Application

            14.7.4. By End-user

            14.7.5. By Country/Sub-region

    15. Middle East & Africa Stem Cells Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Product Type, 2017–2028

            15.2.1. Adult Stem Cell

            15.2.2. Human Embryonic Stem Cell

            15.2.3. Induced Pluripotent Stem Cell

            15.2.4. Others

        15.3. Market Value Forecast, by Source, 2017–2028

            15.3.1. Autologous

            15.3.2. Allogenic

        15.4. Market Value Forecast, by Application, 2017–2028

            15.4.1. Regenerative Medicines

                15.4.1.1. Neurology

                15.4.1.2. Oncology

                15.4.1.3. Cardiology

                15.4.1.4. Others

            15.4.2. Drug Discovery & Development

        15.5. Market Value Forecast, by End-user, 2017–2028

            15.5.1. Therapeutics Companies

            15.5.2. Cell & Tissue Banks

            15.5.3. Tools & Reagents Companies

            15.5.4. Service Companies

        15.6. Market Value Forecast, by Country/Sub-region, 2017–2028

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of MEA

        15.7. Market Attractiveness Analysis

            15.7.1. By Product Type

            15.7.2. By Source

            15.7.3. By Application

            15.7.4. By End-user

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player - Competition Matrix (by tier and size of companies)

        16.2. Market Share/Ranking Analysis, by Company, 2020

        16.3. Company Profiles

            16.3.1. STEMCELL Technologies, Inc.

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Financial Overview

                16.3.1.3. Product Portfolio

                16.3.1.4. SWOT Analysis

                16.3.1.5. Strategic Overview

            16.3.2. Astellas Pharma, Inc.

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Financial Overview

                16.3.2.3. Product Portfolio

                16.3.2.4. SWOT Analysis

                16.3.2.5. Strategic Overview

            16.3.3. Cellular Engineering Technologies, Inc.

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Financial Overview

                16.3.3.3. Product Portfolio

                16.3.3.4. SWOT Analysis

                16.3.3.5. Strategic Overview

            16.3.4. BioTime, Inc.

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Financial Overview

                16.3.4.3. Product Portfolio

                16.3.4.4. SWOT Analysis

                16.3.4.5. Strategic Overview

            16.3.5. Takara Bio, Inc.

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Financial Overview

                16.3.5.3. Product Portfolio

                16.3.5.4. SWOT Analysis

                16.3.5.5. Strategic Overview

            16.3.6. U.S. Stem Cell, Inc.

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Financial Overview

                16.3.6.3. Product Portfolio

                16.3.6.4. SWOT Analysis

                16.3.6.5. Strategic Overview

            16.3.7. BrainStorm Cell Therapeutics, Inc.

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Financial Overview

                16.3.7.3. Product Portfolio

                16.3.7.4. SWOT Analysis

                16.3.7.5. Strategic Overview

            16.3.8. Cytori Therapeutics, Inc.

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Financial Overview

                16.3.8.3. Product Portfolio

                16.3.8.4. SWOT Analysis

                16.3.8.5. Strategic Overview

            16.3.9. Osiris Therapeutics, Inc.

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Financial Overview

                16.3.9.3. Product Portfolio

                16.3.9.4. SWOT Analysis

                16.3.9.5. Strategic Overview

            16.3.10. Caladrius Biosciences, Inc.

                16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.10.2. Financial Overview

                16.3.10.3. Product Portfolio

                16.3.10.4. SWOT Analysis

                16.3.10.5. Strategic Overview

            16.3.11. Other Prominent Players

    List of Table

    Table 01: Global Stem Cells Market Size (US$ Mn) Forecast, by Product Type, 2017–2028

    Table 02: Global Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

    Table 03: Global Stem Cells Market Size (US$ Mn) Forecast, by Application, 2017–2028

    Table 04: Global Stem Cells Market Size (US$ Mn) Forecast, by Application – Regenerative Medicine, 2017–2028

    Table 05: Global Stem Cells Market Size (US$ Mn) Forecast, by End-user, 2017–2028

    Table 06: Global Stem Cells Market Size (US$ Mn) Forecast, by Region, 2017–2028

    Table 07: North America Stem Cells Market Size (US$ Mn) Forecast, by Country, 2017–2028

    Table 08: North America Stem Cells Market Size (US$ Mn) Forecast, by Product, 2017–2028

    Table 09: North America Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

    Table 10: North America Stem Cells Market Size (US$ Mn) Forecast, by Application, 2017–2028

    Table 11: North America Stem Cells Market Size (US$ Mn) Forecast, by Regenerative Medicine, 2017–2028

    Table 12: North America Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

    Table 13: Europe Stem Cells Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

    Table 14: Europe Stem Cells Market Size (US$ Mn) Forecast, by Product, 2017–2028

    Table 15: Europe Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

    Table 16: Europe Stem Cells Market Size (US$ Mn) Forecast, by Application, 2017–2028

    Table 17: Europe Stem Cells Market Size (US$ Mn) Forecast, by Regenerative Medicine, 2017–2028

    Table 18: Europe Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

    Table 19: Asia Pacific Stem Cells Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

    Table 20: Asia Pacific Stem Cells Market Size (US$ Mn) Forecast, by Product, 2017–2028

    Table 21: Asia Pacific Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

    Table 22: Asia Pacific Stem Cells Market Size (US$ Mn) Forecast, by Application, 2017–2028

    Table 23: Asia Pacific Stem Cells Market Size (US$ Mn) Forecast, by Regenerative Medicine, 2017–2028

    Table 24: Asia Pacific Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

    Table 25: Latin America Stem Cells Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

    Table 26: Latin America Stem Cells Market Size (US$ Mn) Forecast, by Product Type, 2017–2028

    Table 27: Latin America Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

    Table 28: Latin America Stem Cells Market Size (US$ Mn) Forecast, by Application, 2017–2028

    Table 29: Latin America Stem Cells Market Size (US$ Mn) Forecast, by Application – Regenerative Medicine, 2017–2028

    Table 30: Latin America Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

    Table 31: Middle East & Africa Stem Cells Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

    Table 32: Middle East & Africa Stem Cells Market Size (US$ Mn) Forecast, by Product Type, 2017–2028

    Table 33: Middle East & Africa Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

    Table 34: Middle East & Africa Stem Cells Market Size (US$ Mn) Forecast, by Application, 2017–2028

    Table 35: Middle East & Africa Stem Cells Market Size (US$ Mn) Forecast, by Application – Regenerative Medicine, 2017–2028

    Table 36: Middle East & Africa Stem Cells Market Size (US$ Mn) Forecast, by Source, 2017–2028

    List of Figure

    Figure 01: Global Stem Cells Market Snapshot

    Figure 02: Revenue Share (2020)

    Figure 03: Key Market Developments

    Figure 04: Market Value Share, by Product, 2020

    Figure 05: Market Value Share, by Source, 2020

    Figure 06: Market Value Share, by Application, 2020

    Figure 07: Market Value Share, by Source, 2020

    Figure 08: Global Stem Cells Market Value Share Analysis, by Product Type, 2017 and 2028

    Figure 09: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y growth (%) Forecast, by Adult Stem Cell, 2017–2028

    Figure 10: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y growth (%) Forecast, by Human Embryonic Stem Cell, 2017–2028

    Figure 11: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y growth (%) Forecast, by Induced Pluripotent Stem Cell, 2017–2028

    Figure 12: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y growth (%) Forecast, by Others, 2017–2028

    Figure 13: Global Stem Cells Market Attractiveness Analysis, by Product Type, 2017–2028

    Figure 14: Global Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

    Figure 15: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Autologous, 2017–2028

    Figure 16: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Allogeneic, 2017–2028

    Figure 17: Global Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

    Figure 18: Global Stem Cells Market Value Share Analysis, by Application, 2017 and 2028

    Figure 19: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Regenerative Medicine, 2017–2028

    Figure 20: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Discovery & Development, 2017–2028

    Figure 21: Global Stem Cells Market Attractiveness Analysis, by Application, 2017–2028

    Figure 22: Global Stem Cells Market Value Share Analysis, by End-user, 2017 and 2028

    Figure 23: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutics Companies, 2017–2028

    Figure 24: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y growth (%) Growth Forecast, by Cell & Tissue Banks, 2017–2028

    Figure 25: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Tools & Reagents Companies, 2017–2028

    Figure 26: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Service Companies, 2017–2028

    Figure 27: Global Stem Cells Market Attractiveness Analysis, by End-user, 2017–2028

    Figure 28: Global Stem Cells Market Value Share Analysis, by Region, 2017 and 2028

    Figure 29: Global Stem Cells Market Attractiveness Analysis, by Region, 2017–2028

    Figure 30: North America Stem Cell Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2017–2028

    Figure 31: North America Stem Cell Market Attractiveness Analysis, by Country, 2017-2028

    Figure 32: North America Stem Cells Market Value Share Analysis, by Country, 2017 and 2028

    Figure 33: North America Stem Cells Market Value Share Analysis, by Product, 2017 and 2028

    Figure 34: North America Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

    Figure 35: North America Stem Cells Market Value Share Analysis, by Application, 2017 and 2028

    Figure 36: North America Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

    Figure 37: North America Stem Cells Market Attractiveness Analysis, by Product, 2017–2028

    Figure 38: North America Stem Cells Market Attractiveness Analysis, by Application, 2017–2028

    Figure 39: North America Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

    Figure 40: North America Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

    Figure 41: Europe Stem Cells Market Size (US$ Mn) and Y-o-Y growth (%) Forecast, 2017–2028

    Figure 42: Europe Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2017-2028

    Figure 43: Europe Stem Cells Market Value Share Analysis, by Country/Sub-region, 2017 and 2028

    Figure 44: Europe Stem Cells Market Value Share Analysis, by Product, 2017 and 2028

    Figure 45: Europe Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

    Figure 46: Europe Stem Cells Market Value Share Analysis, by Application, 2017 and 2028

    Figure 47: Europe Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

    Figure 48: Europe Stem Cells Market Attractiveness Analysis, by Product, 2017–2028

    Figure 49: Europe Stem Cells Market Attractiveness Analysis, by Application, 2017–2028

    Figure 50: Europe Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

    Figure 51: Europe Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

    Figure 52: Asia Pacific Stem Cells Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2017–2028

    Figure 53: Asia Pacific Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2017-2028

    Figure 54: Asia Pacific Stem Cells Market Value Share Analysis, by Country/Sub-region, 2017 and 2028

    Figure 55: Asia Pacific Stem Cells Market Value Share Analysis, by Product, 2017 and 2028

    Figure 56: Asia Pacific Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

    Figure 57: Asia Pacific Stem Cells Market Value Share Analysis, by Application, 2017 and 2028

    Figure 58: Asia Pacific Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

    Figure 59: Asia Pacific Stem Cells Market Attractiveness Analysis, by Product, 2017–2028

    Figure 60: Asia Pacific Stem Cells Market Attractiveness Analysis, by Application, 2017–2028

    Figure 61: Asia Pacific Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

    Figure 62: Asia Pacific Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

    Figure 63: Latin America Stem Cells Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2017–2028

    Figure 64: Latin America Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2017-2028

    Figure 65: Latin America Stem Cells Market Value Share Analysis, by Country/Sub-region, 2017 and 2028

    Figure 66: Latin America Stem Cells Market Value Share Analysis, by Product Type, 2017 and 2028

    Figure 67: Latin America Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

    Figure 68: Latin America Stem Cells Market Value Share Analysis, by Application, 2017 and 2028

    Figure 69: Latin America Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

    Figure 70: Latin America Stem Cells Market Attractiveness Analysis, by Product Type, 2017–2028

    Figure 71: Latin America Stem Cells Market Attractiveness Analysis, by Application, 2017–2028

    Figure 72: Latin America Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

    Figure 73: Latin America Stem Cells Market Attractiveness Analysis, by Source, 2017–2028

    Figure 74: Middle East & Africa Stem Cells Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2017–2028

    Figure 75: Middle East & Africa Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2017-2028

    Figure 76: Middle East & Africa Stem Cells Market Value Share Analysis, by Country/Sub-region, 2017 and 2028

    Figure 77: Middle East & Africa Stem Cells Market Value Share Analysis, by Product Type, 2017 and 2028

    Figure 78: Middle East & Africa Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

    Figure 79: Middle East & Africa Stem Cells Market Value Share Analysis, by Application, 2017 and 2028

    Figure 80: Middle East & Africa Stem Cells Market Value Share Analysis, by Source, 2017 and 2028

    Figure 81: Middle East & Africa Stem Cells Market Attractiveness Analysis, by Product Type, 2017–2028

Copyright © Transparency Market Research, Inc. All Rights reserved